1887

Abstract

Marek’s disease virus (MDV) is the most well-cited example of vaccine-driven virulence evolution. MDV induces a lymphoproliferative disease in chickens, which is currently controlled by widespread vaccination of flocks. Unfortunately, Marek’s disease (MD) vaccines, while effective in preventing tumours, do not prevent viral replication and mutation, which has been hypothesized as the major driving force for increased MDV virulence of field strains during the past 40 years in US commercial flocks. To limit future virulence increases, there is interest in characterizing MDV strain genomes collected over the years and associating genetic variations with variation in virulence. In this study, we characterized 70 MDV genomes with known virulence by complete or targeted DNA sequencing, and identified genetic variants that showed association with virulence. Our results revealed a number of MDV genes as would be expected for a complex trait. In addition, phylogenetic analysis revealed a clear separation of strains that varied by virulence. Interestingly, high virulence isolates from the same farms persisted over years despite eradication attempts, which has implications on control efforts. Given the growing ability to bioengineer the MDV genome, it should be feasible to experimentally test whether these individual variants influence virulence markers alone or combinations. Once validated, these markers may provide an alternative to live bird testing for evaluating virulence of new MDV field strains.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001288
2019-06-11
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/100/7/1132.html?itemId=/content/journal/jgv/10.1099/jgv.0.001288&mimeType=html&fmt=ahah

References

  1. Kurath G, Wargo A, Weaver S, Denison M, Roossinck M et al. Evolution of Viral Virulence: Empirical Studies Academic Press Caister; 2015
    [Google Scholar]
  2. Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA. Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol 2005; 34:75–90 [View Article]
    [Google Scholar]
  3. Witter RL. Increased virulence of Marek's disease virus field isolates. Avian Dis 1997; 41:149–163 [View Article]
    [Google Scholar]
  4. Witter RL. The changing landscape of Marek's disease. Avian Pathol 1998; 27:S46–S53 [View Article]
    [Google Scholar]
  5. Nair V. Evolution of Marek's disease - a paradigm for incessant race between the pathogen and the host. Vet J 2005; 170:175–183 [View Article]
    [Google Scholar]
  6. Read AF, Baigent SJ, Powers C, Kgosana LB, Blackwell L et al. Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biol 2015; 13:e1002198 [View Article]
    [Google Scholar]
  7. Dunn JR, Silva RF, Lee LF, Witter RL. Competition between two virulent Marek's disease virus strains in vivo . Avian Pathol 2012; 41:267–275 [View Article]
    [Google Scholar]
  8. Qian Z, Brunovskis P, Rauscher F 3rd, Lee L, Kung HJ. Transactivation activity of MEQ, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J Virol 1995; 69:4037–4044
    [Google Scholar]
  9. Shamblin CE, Greene N, Arumugaswami V, Dienglewicz RL, Parcells MS. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of MEQ mutations with MDVs of high virulence. Vet Microbiol 2004; 102:147–167 [View Article]
    [Google Scholar]
  10. Renz KG, Cooke J, Clarke N, Cheetham BF, Hussain Z et al. Pathotyping of Australian isolates of Marek's disease virus and association of pathogenicity with MEQ gene polymorphism. Avian Pathol 2012; 41:161–176 [View Article]
    [Google Scholar]
  11. Spatz SJ, Petherbridge L, Zhao Y, Nair V. Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus. J Gen Virol 2007; 88:1080–1096 [View Article]
    [Google Scholar]
  12. Spatz SJ, Silva RF. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1. Virus Genes 2007; 35:41–53 [View Article]
    [Google Scholar]
  13. Spatz SJ, Silva RF. Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes. Arch Virol 2007; 152:1665–1678 [View Article]
    [Google Scholar]
  14. Santin ER, Shamblin CE, Prigge JT, Arumugaswami V, Dienglewicz RL et al. Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek's disease virus pathogenesis. Avian Dis 2006; 50:96–103 [View Article]
    [Google Scholar]
  15. Tavlarides-Hontz P, Kumar PM, Amortegui JR, Osterrieder N, Parcells MS. A deletion within glycoprotein L of Marek's disease virus (MDV) field isolates correlates with a decrease in bivalent MDV vaccine efficacy in contact-exposed chickens. Avian Dis 2009; 53:287–296 [View Article]
    [Google Scholar]
  16. Jarosinski KW, Osterrieder N, Nair VK, Schat KA. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J Virol 2005; 79:11647–11659 [View Article]
    [Google Scholar]
  17. Hildebrandt E, Dunn JR, Perumbakkam S, Niikura M, Cheng HH. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence. J Virol 2014; 88:6232–6242 [View Article]
    [Google Scholar]
  18. Trimpert J, Groenke N, Jenckel M, He S, Kunec D et al. A phylogenomic analysis of Marek's disease virus reveals independent paths to virulence in Eurasia and North America. Evol Appl 2017; 10:1091–1101 [View Article]
    [Google Scholar]
  19. Bacon LD, Hunt HD, Cheng HH. A review of the development of chicken lines to resolve genes determining resistance to diseases. Poult Sci 2000; 79:1082–1093 [View Article]
    [Google Scholar]
  20. Sevoian M, Chamberlain DM, Counter FT. Avian lymphomatosis. I. Experimental reproduction of the neural and visceral forms. Veterinary Medicine 1962; 57:500–501
    [Google Scholar]
  21. Witter RL. Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis 1983; 27:113–132 [View Article]
    [Google Scholar]
  22. Witter RL. Increased virulence of Marek's disease virus field isolates. Avian Dis 1997; 41:149–163 [View Article]
    [Google Scholar]
  23. Witter RL, Sharma JM, Fadly AM. Pathogenicity of variant Marek's disease virus Isolants in vaccinated and unvaccinated chickens. Avian Dis 1980; 24:210–232 [View Article]
    [Google Scholar]
  24. Witter RL, Kreager KS. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease. Avian Dis 2004; 48:768–782 [View Article]
    [Google Scholar]
  25. Witter RL, Nazerian K, Purchase HG, Burgoyne GH. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res 1970; 31:525–538
    [Google Scholar]
  26. Schat KA, Calnek BW. Characterization of an apparently nononcogenic Marek's disease virus. J Natl Cancer Inst 1978; 60:1075–1082 [View Article]
    [Google Scholar]
  27. Joshi NA. 2011; Sickle: a sliding-window, adaptive, quality-based trimming tool for FastQ files (version 1.33). https://github.com/najoshi/sickle
  28. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357–359 [View Article]
    [Google Scholar]
  29. Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 2011; 27:2987–2993 [View Article]
    [Google Scholar]
  30. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22:568–576 [View Article]
    [Google Scholar]
  31. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010; 59:307–321 [View Article]
    [Google Scholar]
  32. Paradis E, Schliep K. Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics 2019; 35:526–528 [View Article]
    [Google Scholar]
  33. Mitchell AL, Attwood TK, Babbitt PC, Blum M, Bork P et al. InterPro in 2019: improving coverage, classification and access to protein sequence annotations. Nucleic Acids Res 2019; 47:D351–D360 [View Article]
    [Google Scholar]
  34. Hunt HD. Marek's disease virus evolution in specific MHC haplotypes [abstract], 9th International Symposium on Marek's Disease and Avian Herpesviruses. Berlin, Germany: 2012 p 41
    [Google Scholar]
  35. Gimeno IM, Witter RL, Neumann U. Neuropathotyping: a new system to classify Marek's disease virus. Avian Dis 2002; 46:909–918 [View Article]
    [Google Scholar]
  36. Calnek BW, Harris RW, Buscaglia C, Schat KA, Lucio B. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis 1998; 42:124–132 [View Article]
    [Google Scholar]
  37. Dunn JR, Auten K, Heidari M, Buscaglia C. Correlation between Marek's disease virus pathotype and replication. Avian Dis 2014; 58:287–292 [View Article]
    [Google Scholar]
  38. Lyons DM, Lauring AS. Evidence for the selective basis of transition-to-transversion substitution bias in two RNA viruses. Mol Biol Evol 2017; 34:3205–3215 [View Article]
    [Google Scholar]
  39. Kennedy DA, Dunn JR, Dunn PA, Read AF. An observational study of the temporal and spatial patterns of Marek's-disease-associated leukosis condemnation of young chickens in the United States of America. Prev Vet Med 2015; 120:328–335 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001288
Loading
/content/journal/jgv/10.1099/jgv.0.001288
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 1

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error